Page last updated: 2024-09-02

fingolimod hydrochloride and Cystic Fibrosis

fingolimod hydrochloride has been researched along with Cystic Fibrosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Becker, KA; Edwards, MJ; Futerman, AH; Grassmé, H; Gulbins, E; Japtok, L; Joseph, T; Kleuser, B; Lang, S; Lentsch, AB; Pewzner-Jung, Y; Schuchman, EH; Steinmann, J; Tavakoli Tabazavareh, S; Tuemmler, B	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Cystic Fibrosis

Article	Year
Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa. EMBO molecular medicine, 2014, Volume: 6, Issue:9 Topics: Acid Ceramidase; Administration, Inhalation; Animals; Ceramides; Cystic Fibrosis; Disease Susceptibility; Fingolimod Hydrochloride; Humans; Mice, Inbred C57BL; Mice, Transgenic; Propylene Glycols; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sphingosine; Trachea	2014

Article

Year

Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa.

EMBO molecular medicine, 2014, Volume: 6, Issue:9

Topics: Acid Ceramidase; Administration, Inhalation; Animals; Ceramides; Cystic Fibrosis; Disease Susceptibility; Fingolimod Hydrochloride; Humans; Mice, Inbred C57BL; Mice, Transgenic; Propylene Glycols; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sphingosine; Trachea

2014